High Blood Pressure (Hypertension) Completed Phase 4 Trials for Olmesartan (DB00275)

Also known as: HTN / Hypertension(HTN) / Hypertensive / Hypertension / High Blood Pressure / Blood High Pressure / Blood Pressure, High / High Blood Pressures / Blood pressure high / Essential (primary) hypertension / HT / HBP / Hypertension NOS / Hypertension arterial

IndicationStatusPhase
DBCOND0040789 (High Blood Pressure (Hypertension))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01101009Comparison of SevikarĀ® and the Combination of Perindopril/Amlodipine on Central Blood PressureTreatment
NCT01684748Angiotensin II Blockade and Inflammation in ObesityPrevention
NCT00858702Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in HypertensionTreatment
NCT01611077Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgTreatment
NCT00134160OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyPrevention
NCT00185120Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel BlockerTreatment
NCT00185094A Comparison of the Effect of Olmesartan Medoxomil, Losartan Potassium, and Atenolol on the Ability of Overweight Patients With High Blood Pressure to Respond to InsulinTreatment
NCT00185068An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of BenicarĀ® and BenicarĀ® HCT in Patients With HypertensionTreatment
NCT00295542Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of ChronotherapyTreatment
NCT00403481An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II DiabetesTreatment
NCT00412932An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With HypertensionTreatment
NCT0065474518 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 DiabeticsTreatment
NCT00796159Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
NCT00949884Olmesartan Comparison to Losartan in Hypertensive SubjectsTreatment